Trials / Completed
CompletedNCT01219140
Pomegranate Extract Biomarker Study in Osteopenic Women
A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial to Evaluate the Safety and Efficacy of Pomegranate Extract Capsules in Post-Menopausal Subjects With Decreased Bone Mineral Density
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- POM Wonderful LLC · Industry
- Sex
- Female
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Treatment of post-menopausal subjects (with decreased bone mineral density) with pomegranate extract capsules will produce statistically significant changes in biomarkers for bone resorption and formation when compared to subjects receiving placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 2 POMx Capsules | 2 POMx Capsules daily |
| DIETARY_SUPPLEMENT | 2 placebo Capsules | 2 placebo Capsules daily |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2010-10-13
- Last updated
- 2010-10-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01219140. Inclusion in this directory is not an endorsement.